Medical Affairs, MSD K.K., Tokyo, Japan.
Risk Assessment & Pharmacoepidemiology, MSD K.K., Tokyo, Japan.
Hum Vaccin Immunother. 2020;16(1):132-137. doi: 10.1080/21645515.2019.1638204. Epub 2019 Aug 1.
This is an extension of our previous study, which evaluated the incidence of seasonal rotavirus gastroenteritis (RVGE) hospitalizations in children aged <5 years from 2009 to 2015 in Japan. Here, we evaluated the incidence of RVGE hospitalizations in children aged <10 years during the rotavirus season (January‒June) from 2009 to 2017 in Japan, before and after the monovalent and pentavalent rotavirus vaccines were introduced in November 2011 and July 2012, using the same health insurance claims database and study methods. In children aged <5 years, the incidence of RVGE hospitalizations greatly declined in 2014 after vaccine introduction, consistent with our previous findings, and the decline was sustained until 2017. However, in children aged ≥5‒<10 years, no apparent trend for a continuous decline in RVGE hospitalizations was observed during the study period. Improved RV vaccination coverage may lead to a further reduction in severe RVGE in Japan.
这是我们之前研究的延伸,评估了 2009 年至 2015 年日本年龄<5 岁儿童季节性轮状病毒胃肠炎(RVGE)住院的发病率。在这里,我们评估了 2009 年至 2017 年日本轮状病毒季节(1 月至 6 月)期间年龄<10 岁儿童的 RVGE 住院发病率,使用相同的医疗保险索赔数据库和研究方法,在 2011 年 11 月和 2012 年 7 月引入单价和五价轮状病毒疫苗之前和之后。在年龄<5 岁的儿童中,疫苗接种后,2014 年 RVGE 住院的发病率大幅下降,与我们之前的发现一致,这种下降一直持续到 2017 年。然而,在年龄≥5 至<10 岁的儿童中,在研究期间,RVGE 住院的发病率没有明显的持续下降趋势。RV 疫苗接种覆盖率的提高可能会导致日本严重 RVGE 的进一步减少。